Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
614381000001114 | Efexor XL 75mg capsules (Upjohn UK Ltd) 14 capsule 2 x 7 capsules | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
614391000001111 | Efexor XL 75mg capsules (Upjohn UK Ltd) 14 capsule 2 x 7 capsules (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1257271000001117 | Efexor XL 75mg capsules (Upjohn Ltd) 14 capsule 2 x 7 capsules | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
1257281000001115 | Efexor XL 75mg capsules (Upjohn Ltd) 14 capsule 2 x 7 capsules (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2167361000001113 | Efexor XL 75mg capsules (Viatris UK Healthcare Ltd) 14 capsule 2 x 7 capsules | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
2167371000001115 | Efexor XL 75mg capsules (Viatris UK Healthcare Ltd) 14 capsule 2 x 7 capsules (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
41066001000001119 | Efexor XL 75mg capsules (Wyeth Pharmaceuticals) 14 capsule 2 x 7 capsules (product) | en | Fully specified name | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
41066101000001118 | Efexor XL 75mg capsules (Wyeth Pharmaceuticals) 14 capsule 2 x 7 capsules | en | Synonym | Inactive | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
59594101000001114 | Efexor XL 75mg capsules (Pfizer Ltd) 14 capsule 2 x 7 capsules | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets